Digestive and Liver Disease
Volume 43, Issue 2 , Pages 102-109 , February 2011

Health-related quality of life is impaired in active collagenous colitis

  • Henrik Hjortswang

      Affiliations

    • Department of Gastroenterology and Endocrinology, Division of Gastroenterology and Hepatology, Linköping University Hospital, Faculty of Health Sciences, Linköping University, Sweden
    • Swedish Organization for the study of Inflammatory Bowel Disease (SOIBD), a national organization for gastroenterologists, colorectal surgeons and basic scientists.
    • Corresponding Author InformationCorresponding author. Fax: +46 13 223506.
  • ,
  • Curt Tysk

      Affiliations

    • Division of Gastroenterology, Department of Medicine, Örebro University Hospital, School of Health and Medical Sciences, Örebro University, Örebro, Sweden
    • Swedish Organization for the study of Inflammatory Bowel Disease (SOIBD), a national organization for gastroenterologists, colorectal surgeons and basic scientists.
  • ,
  • Johan Bohr

      Affiliations

    • Division of Gastroenterology, Department of Medicine, Örebro University Hospital, School of Health and Medical Sciences, Örebro University, Örebro, Sweden
    • Swedish Organization for the study of Inflammatory Bowel Disease (SOIBD), a national organization for gastroenterologists, colorectal surgeons and basic scientists.
  • ,
  • Cecilia Benoni

      Affiliations

    • Division of Gastroenterology, Department of Medicine, MAS University Hospital, Malmö, Sweden
    • Swedish Organization for the study of Inflammatory Bowel Disease (SOIBD), a national organization for gastroenterologists, colorectal surgeons and basic scientists.
  • ,
  • Lina Vigren

      Affiliations

    • Division of Gastroenterology, Department of Medicine, MAS University Hospital, Malmö, Sweden
  • ,
  • Anders Kilander

      Affiliations

    • Division of Gastroenterology, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    • Swedish Organization for the study of Inflammatory Bowel Disease (SOIBD), a national organization for gastroenterologists, colorectal surgeons and basic scientists.
  • ,
  • Lasse Larsson

      Affiliations

    • Division of Gastroenterology, Department of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
  • ,
  • Yesuf Taha

      Affiliations

    • Department of Gastroenterology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
  • ,
  • Magnus Ström

      Affiliations

    • Department of Gastroenterology and Endocrinology, Division of Gastroenterology and Hepatology, Linköping University Hospital, Faculty of Health Sciences, Linköping University, Sweden
    • Swedish Organization for the study of Inflammatory Bowel Disease (SOIBD), a national organization for gastroenterologists, colorectal surgeons and basic scientists.

Received 13 January 2010 ,Accepted 1 June 2010.

References 

  1. Lindström CG. ‘Collagenous colitis’ with watery diarrhea. A new entity. Pathol Eur. 1976;11:87–89
  2. Tysk C, Bohr J, Nyhlin N, et al. Diagnosis and management of microscopic colitis. World J Gastroenterol. 2008;14:7280–7288
  3. Jessurun J, Yardley JH, Giardiello FM, et al. Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathological findings in 15 patients. Hum Pathol. 1987;18:839–848
  4. Bohr J, Tysk C, Eriksson S, et al. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut. 1996;39:846–851
  5. Olesen M, Eriksson S, Bohr J, et al. Microscopic colitis: a common diarrheal disease. An epidemiological study in Örebro, Sweden, 1993–1998. Gut. 2004;53:346–350
  6. Agnarsdottir M, Gunnlaugsson O, Orvar KB, et al. Collagenous and lymphocytic colitis in Iceland. Dig Dis Sci. 2002;47:1122–1128
  7. Pardi DS, Loftus EV, Smyrk TC, et al. The epidemiology of microscopic colitis: a population-based study in Olmsted County, Minnesota. Gut. 2007;56:504–508
  8. Feyen B, Wall GC, Finnerty EP, et al. Meta-analysis: budesonide treatment for collagenous colitis. Aliment Pharmacol Therap. 2004;20:745–749
  9. Chande N, McDonald JW, Macdonald JK. Interventions for treating collagenous colitis. Cochrane Database Syst Rev. 2008;CD003575
  10. Bonderup OK, Hansen JB, Birket-Smith L, et al. Budesonide treatment of collagenous colitis: a randomized, double blind, placebo controlled trial with morphometric analysis. Gut. 2003;52:248–251
  11. Miehlke S, Heymer P, Bethke B, et al. Budesonide treatment for collagenous colitis: a randomized, double-blind, placebo-controlled, multicenter trial. Gastroenterology. 2002;123:978–984
  12. Miehlke S, Madisch A, Bethke B, et al. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide. Aliment Pharmacol Therap. 2005;22:1115–1119
  13. Bonderup OK, Hansen JB, Teglbjaerg PS, et al. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo controlled trial. Gut. 2009;58:68–72
  14. Madisch A, Heymer P, Voss C, et al. Oral budesonide therapy improves quality of life in patients with collagenous colitis. Int J Colorect Dis. 2005;20:312–316
  15. Miehlke S, Madisch A, Bethke B, et al. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2008;135:1510–1516
  16. Ware JE, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–481
  17. McHorney CA, Ware JE, Rogers W, et al. The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. Med Care. 1992;30(Suppl.):MS253–MS265
  18. McHorney CA, Ware JE, Raczek AE. The MOS 36-item Short-Form Health Survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247–263
  19. Dupuy HJ. The psychological general well-being (PGWB) index. In:  Wenger NK,  Mattson ME,  Furberg CF,  Elinson J editor. Assessment of quality of life in clinical trials of cardiovascular therapies. USA: Le Jacq Publishing Inc.; 1984;p. 170–183
  20. Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989;96:804–810
  21. Irvine EJ, Feagan B, Rochon J, et al. Quality of life: a valid and reliable measure of the therapeutic efficacy in the treatment of inflammatory bowel disease. Gastroenterology. 1994;106:287–296
  22. Drossman DA, Leserman J, Li Z, et al. The Rating Form of IBD Patient Concerns: a new measure of health status. Psychosom Med. 1991;53:701–712
  23. Sullivan M, Karlsson J, Ware JE. SF-36 Hälsoenkät: Svensk manual och tolkningsguide [Swedish manual and interpretation guide]. Gothenburg: Sahlgrenska University Hospital; 1994;
  24. Wiklund I, Karlberg J. Evaluation of quality of life in clinical trials: selecting quality of life measures. Control Clin Trials. 1991;12:S204–216
  25. Hjortswang H, Järnerot G, Curman B, et al. Validation of the inflammatory bowel disease questionnaire (IBDQ) in Swedish patients with ulcerative colitis. Scand J Gastroenterol. 2001;36:77–85
  26. Stjernman H, Grännö C, Bodemar G, et al. Evaluation of the inflammatory bowel disease questionnaire in Swedish patients with Crohn's disease. Scand J Gastroenterol. 2006;41:934–943
  27. Hjortswang H, Ström M, Almeida RT, et al. Evaluation of the RFIPC, a disease-specific health-related quality of life questionnaire, in Swedish patients with ulcerative colitis. Scand J Gastroenterol. 1997;32:1235–1240
  28. Hjortswang H, Tysk C, Bohr J, et al. Defining clinical criteria for clinical remission and disease activity in collagenous colitis. Inflamm Bowel Dis. 2009;15:1875–1881
  29. Sullivan M, Karlsson J. The Swedish SF-36 Health Survey III. Evaluation of criterion-based validity: results from normative population. J Clin Epidemiol. 1998;51:1105–1113

PII: S1590-8658(10)00210-0

doi: 10.1016/j.dld.2010.06.004

Digestive and Liver Disease
Volume 43, Issue 2 , Pages 102-109 , February 2011